Pharma Two B to Present Additional Positive Results from
Results showed P2B001, a once-daily fixed-dose combination of low dose pramipexole and low dose rasagiline, showed comparable efficacy to marketed...
Source: globenewswire.com
Stay updated with breaking news from 2b001. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Results showed P2B001, a once-daily fixed-dose combination of low dose pramipexole and low dose rasagiline, showed comparable efficacy to marketed...
Study successfully met its primary and key secondary endpoints, demonstrating superior efficacy of P2B001 compared to its individual components P2B001 showed comparable efficacy to a marketed